Advisory Committee Business and Operations; Notice of Meeting, 18737-18738 [2014-07438]

Download as PDF Federal Register / Vol. 79, No. 64 / Thursday, April 3, 2014 / Notices of this public interest factor because: (1) The witnesses did not specifically mention controlled substances; (2) they were not asked follow-up questions that would have given context to these comments; and (3) they were not wellinformed about the facts involved in the Respondent’s history of drug abuse or his drug-related conviction. Finally, I am not persuaded by Respondent’s testimony that his registration is in the ‘‘best interest of the community,’’ 125 because long-standing agency precedent indicates this is not a relevant consideration. See e.g., Linda Sue Cheek, M.D., 76 FR at 66973. pmangrum on DSK3VPTVN1PROD with NOTICES C. Conclusion and Recommendation I conclude that the Government has proven, by a preponderance of the evidence, that Respondent’s renewal application for DEA COR No. FK1953327 in Minnesota should be denied and Respondent’s DEA COR No. BK1391729 in Alabama should be revoked. Respondent has been granted numerous opportunities to act as a responsible DEA registrant and has failed each time. I do not see any conditions that could be placed on Respondent’s registration now that would ensure that Respondent would be a responsible DEA registrant, especially considering that Respondent has been the subject of numerous state medical board orders that imposed probationary periods, that Respondent violated his DEA MOA, and that Respondent recently pled guilty to a felony concerning controlled substances. Furthermore, Respondent has not shown that he has learned from his past mistakes in a way that will prevent future misconduct. Although Respondent offered ample testimony concerning his reputation as a practicing physician and his impact on the medical community, the only probative mitigating evidence offered was generalized testimony about his ability to handle prescription drugs. Because Respondent has not taken full responsibility for his mistakes and genuinely expressed remorse, I find that granting Respondent’s renewal application for the DEA COR in Minnesota is against the public interest and revoking Respondent’s DEA COR in Alabama is appropriate. Consequently, I recommend that Dr. Koch’s renewal application for DEA COR No. FK1953327 be denied and DEA Registration No. BK1391729 be revoked. Dated: July 18, 2013. Gail A. Randall, 125 [Tr. 229; Resp’t Brief, at 4]. VerDate Mar<15>2010 15:17 Apr 02, 2014 Jkt 232001 Administrative Law Judge. [FR Doc. 2014–07450 Filed 4–2–14; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF LABOR Wage and Hour Division Presidential Memorandum of March 13, 2014; Updating and Modernizing Overtime Regulations Wage and Hour Division, Department of Labor. ACTION: Notice. AGENCY: On March 13, 2014, President Barack Obama issued a memorandum to the Secretary of Labor, directing him to modernize and streamline the existing overtime regulations for executive, administrative and professional employees. The last change to these overtime regulations was in 2004. The text of this memorandum reads— The Fair Labor Standards Act (the ‘‘Act’’), 29 U.S.C. 201 et seq., provides basic rights and wage protections for American workers, including Federal minimum wage and overtime requirements. Most workers covered under the Act must receive overtime pay of at least 1.5 times their regular pay rate for hours worked in excess of 40 hours per week. However, regulations regarding exemptions from the Act’s overtime requirement, particularly for executive, administrative, and professional employees (often referred to as ‘‘white collar’’ exemptions) have not kept up with our modern economy. Because these regulations are outdated, millions of Americans lack the protections of overtime and even the right to the minimum wage. Therefore, I hereby direct you to propose revisions to modernize and streamline the existing overtime regulations. In doing so, you shall consider how the regulations could be revised to update existing protections consistent with the intent of the Act; address the changing nature of the workplace; and simplify the regulations to make them easier for both workers and businesses to understand and apply. This memorandum is not intended to, and does not, create any right or benefit, substantive or procedural, enforceable at law or in equity by any party against the United States, its departments, agencies, or entities, its officers, employees, or agents, or any other person. Nothing in this memorandum shall be construed to impair or otherwise affect the authority granted by law to a PO 00000 Frm 00075 Fmt 4703 Sfmt 4703 18737 department or agency, or the head thereof. You are hereby authorized and directed to publish this memorandum in the Federal Register. FOR FURTHER INFORMATION CONTACT: Mary Ziegler, Director, Division of Regulations, Legislation, and Interpretation, Wage and Hour, U.S. Department of Labor, Room S–3502, 200 Constitution Avenue NW., Washington, DC 20210; telephone: (202) 693–0406 (this is not a toll-free number). Copies of this notice may be obtained in alternative formats (Large Print, Braille, Audio Tape, or Disc), upon request, by calling (202) 693–0023 (not a toll-free number). TTY/TTD callers may dial tollfree (877) 889–5627 to obtain information or request materials in alternative formats. Dated: March 21, 2014. Laura A. Fortman, Principal Deputy Administrator, Wage and Hour Division. [FR Doc. 2014–07379 Filed 4–2–14; 8:45 am] BILLING CODE 4510–27–P NATIONAL SCIENCE FOUNDATION Advisory Committee Business and Operations; Notice of Meeting In accordance with Federal Advisory Committee Act (Pub. L. 92–463, as amended), the National Science Foundation announces the following meeting: Name: Business and Operations Advisory Committee (9556). Date/Time: April 30, 2014; 1:00 p.m. to 5:30 p.m. (EST); May 1, 2014; 8:00 a.m. to 12:00 p.m. (EST). Place: National Science Foundation, 4201 Wilson Boulevard, Stafford I, Room 1235. Type of Meeting: OPEN. Contact Person: Joan Miller, National Science Foundation, 4201 Wilson Boulevard, Arlington, VA 22230, (703) 292–8200. Purpose of Meeting: To provide advice concerning issues related to the oversight, integrity, development and enhancement of NSF’s business operations. Agenda: Wednesday, April 30, 2014 1:00 p.m.– 5:30 p.m.: Welcome/Introductions; BFA/OIRM/CIO Updates; OMB Publication of Uniform Guidance; Report from Working Group to Consider the Issue of Linking NSF Organizational Goals and Objectives with Employee Performance Plans; Virtual Panels. Thursday, May 1, 2014 8:00 a.m.–12:00 p.m.: Business Systems Review (BSR) E:\FR\FM\03APN1.SGM 03APN1 18738 Federal Register / Vol. 79, No. 64 / Thursday, April 3, 2014 / Notices Process; Prepare for Meeting with Dr. Marrett; Discussion with Dr. Marrett; Closing Discussion. Dated: March 31, 2014. Suzanne Plimpton, Acting Committee Management Officer. [FR Doc. 2014–07438 Filed 4–2–14; 8:45 am] BILLING CODE 7555–01–P NUCLEAR REGULATORY COMMISSION [NRC–2014–0001] Sunshine Act Meeting Notice Week of March 31, 2014. PLACE: Commissioners’ Conference Room, 11555 Rockville Pike, Rockville, Maryland. STATUS: Public and Closed. DATES: public meetings in another format (e.g. braille, large print), please notify Kimberly Meyer, NRC Disability Program Manager, at 301–287–0727, or by email at Kimberly.Meyer-Chambers@ nrc.gov. Determinations on requests for reasonable accommodation will be made on a case-by-case basis. * * * * * Members of the public may request to receive this information electronically. If you would like to be added to the distribution, please contact the Office of the Secretary, Washington, DC 20555 (301–415–1969), or send an email to Darlene.Wright@nrc.gov. Dated: April 1, 2014. Rochelle C. Bavol, Policy Coordinator, Office of the Secretary. 3:30 p.m. Affirmation Session (Public Meeting) (Tentative) Florida Power & Light Co. (St. Lucie Plant, Unit 2), Docket No. 50–389, Motion to Stay Restart Pending Conclusion of Hearing Regarding De Facto Amendment of Operating License (March 10, 2014) (Tentative) This meeting will be webcast live at the Web address—https://www.nrc.gov/. * * * * * * The schedule for Commission meetings is subject to change on short notice. To verify the status of meetings, call (recording)—301–415–1292. Contact person for more information: Rochelle Bavol, 301–415–1651. * * * * * ADDITIONAL INFORMATION pmangrum on DSK3VPTVN1PROD with NOTICES Dated: March 27, 2014. Karen A. Cook, General Counsel. [FR Doc. 2014–07436 Filed 4–2–14; 8:45 am] BILLING CODE 4310–4R–P REAGAN-UDALL FOUNDATION FOR THE FOOD AND DRUG ADMINISTRATION [BAC 416404] Annual Public Meeting ACTION: BILLING CODE 7590–01–P Notice of annual meeting. The Reagan-Udall Foundation for the Food and Drug Administration (FDA), which was created by Title VI of the Food and Drug Amendments of 2007, is announcing an annual open public meeting. The Foundation will provide an overview of its history, project updates, as well as projected activities going forward. DATES: The open public meeting will be held on May 14, 2014, from 10 a.m. until 12 p.m. Interested persons may sign up to attend in person and/or make comments at the meeting or submit written comments by visiting https:// www.ReaganUdall.org on or before May 6, 2014. Oral comments from the public will be scheduled between approximately 11 a.m. and 12 p.m. Time allotted for each registrant will be 3 minutes. The contact person will notify interested persons regarding their request to speak by May 9, 2014. Written comments are encouraged. Those individuals interested in making formal comments should notify the contact person and submit a brief statement of the general nature of the comments they wish to present. Written comments are encouraged through May 12, 2014. ADDRESSES: The public meeting will be held at 901 East Conference Center, The Pew Charitable Trusts, 901 East St. NW., Washington, DC 20004. FOR FURTHER INFORMATION CONTACT: Jane Reese-Coulbourne, Reagan-Udall Foundation for the FDA, 202–828–1206, Meetings@ReaganUdall.org. SUPPLEMENTARY INFORMATION: SUMMARY: Tuesday, April 1, 2014 By a vote of 5–0 on March 31, 2014, the Commission determined pursuant to U.S.C. 552b(e) and § 9.107(a) of the Commission’s rules that the above referenced Affirmation Session be held with less than one week notice to the public. The meeting is scheduled on April 1, 2014. * * * * * The NRC Commission Meeting Schedule can be found on the Internet at: https://www.nrc.gov/public-involve/ public-meetings/schedule.html. * * * * * The NRC provides reasonable accommodation to individuals with disabilities where appropriate. If you need a reasonable accommodation to participate in these public meetings, or need this meeting notice or the transcript or other information from the 15:17 Apr 02, 2014 Karen Cook, General Counsel, the Presidio Trust, 103 Montgomery Street, P.O. Box 29052, San Francisco, California 94129–0052, Telephone: 415– 561–5300. [FR Doc. 2014–07608 Filed 4–1–14; 4:15 pm] Week of March 31, 2014 VerDate Mar<15>2010 FOR FURTHER INFORMATION CONTACT: Jkt 232001 PRESIDIO TRUST Notice of Public Meeting The Presidio Trust. Notice of Public Meeting. AGENCY: ACTION: In accordance with § 103(c)(6) of the Presidio Trust Act, 16 U.S.C. 460bb appendix, and in accordance with the Presidio Trust’s bylaws, notice is hereby given that a public meeting of the Presidio Trust Board of Directors will be held commencing 6:30 p.m. on Thursday, April 24, 2014, at the Observation Post, 211 Lincoln Boulevard, Presidio of San Francisco, California. The Presidio Trust was created by Congress in 1996 to manage approximately eighty percent of the former U.S. Army base known as the Presidio, in San Francisco, California. The purposes of this meeting are to take action on the minutes of a previous Board meeting, to provide the Chairperson’s report, to provide the Executive Director’s report, to provide a remediation program update, to provide an Officers’ Club update and take action on a related construction project, to provide a Presidio Gateway project update, and to receive public comment in accordance with the Trust’s Public Outreach Policy. Individuals requiring special accommodation at this meeting, such as needing a sign language interpreter, should contact Mollie Matull at 415–561–5300 prior to April 17, 2014. Time: The meeting will begin at 6:30 p.m. on Thursday, April 24, 2014. ADDRESSES: The meeting will be held at the Observation Post, 211 Lincoln Boulevard, Presidio of San Francisco. SUMMARY: PO 00000 Frm 00076 Fmt 4703 Sfmt 4703 I. Background The Reagan-Udall Foundation for the FDA (the Foundation) is an independent 501(c)(3) not-for-profit organization E:\FR\FM\03APN1.SGM 03APN1

Agencies

[Federal Register Volume 79, Number 64 (Thursday, April 3, 2014)]
[Notices]
[Pages 18737-18738]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-07438]


=======================================================================
-----------------------------------------------------------------------

NATIONAL SCIENCE FOUNDATION


Advisory Committee Business and Operations; Notice of Meeting

    In accordance with Federal Advisory Committee Act (Pub. L. 92-463, 
as amended), the National Science Foundation announces the following 
meeting:
    Name: Business and Operations Advisory Committee (9556).
    Date/Time: April 30, 2014; 1:00 p.m. to 5:30 p.m. (EST); May 1, 
2014; 8:00 a.m. to 12:00 p.m. (EST).
    Place: National Science Foundation, 4201 Wilson Boulevard, Stafford 
I, Room 1235.
    Type of Meeting: OPEN.
    Contact Person: Joan Miller, National Science Foundation, 4201 
Wilson Boulevard, Arlington, VA 22230, (703) 292-8200.
    Purpose of Meeting: To provide advice concerning issues related to 
the oversight, integrity, development and enhancement of NSF's business 
operations.
    Agenda:
Wednesday, April 30, 2014 1:00 p.m.-5:30 p.m.: Welcome/Introductions; 
BFA/OIRM/CIO Updates; OMB Publication of Uniform Guidance; Report from 
Working Group to Consider the Issue of Linking NSF Organizational Goals 
and Objectives with Employee Performance Plans; Virtual Panels.
Thursday, May 1, 2014 8:00 a.m.-12:00 p.m.: Business Systems Review 
(BSR)

[[Page 18738]]

Process; Prepare for Meeting with Dr. Marrett; Discussion with Dr. 
Marrett; Closing Discussion.

    Dated: March 31, 2014.
Suzanne Plimpton,
Acting Committee Management Officer.
[FR Doc. 2014-07438 Filed 4-2-14; 8:45 am]
BILLING CODE 7555-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.